Stockreport

Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma

Bausch + Lomb Corporation  (BLCO) 
PDF Both primary effectiveness endpoints were met, demonstrating statistically significant and clinically meaningful intraocular pressure reduction.ELIOS is an implant-free [Read more]